GlassScriptPhysician profile
June Sigman
NPI 1003877192
$890.40
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2021: $549.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $164.28 | 2021 | |
| Merck Sharp & Dohme LLC | $131.89 | 2019 | |
| Myovant Sciences INC. | $125.00 | 2021 | |
| Urovant Sciences INC | $125.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $121.23 | 2021 | |
| Intuitive Surgical, INC. | $84.97 | 2019 | |
| Siemens Medical Solutions USA, INC. | $13.04 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw June Sigman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.